This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BOOK BY MIDNIGHT OCTOBER 29 TO SAVE $400!

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Udaya Rangaswamy, Ph.D.
Senior Scientist at Teneobio

Profile

Dr. Rangaswamy is a senior scientist at Teneobio, Inc., a company focused on discovery and development of novel multi-specific antibodies for cancer therapy. Dr. Rangaswamy is a project lead for several candidate multispecific antibodies in oncology. She also oversees strategy for optimization and selection of lead candidates for Teneobio’s therapeutic T cell bispecific antibody pipeline. Dr. Rangaswamy earned her PhD in Microbiology and Molecular Genetics at Emory University and was a post-doctoral fellow at MedImmune/Astrazeneca prior to joining Teneobio.

Agenda Sessions

  • Mitigating Cytokine Release with Novel Low Affinity Anti-CD3 based T-Cell Engagers

    4:45pm